{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T13:21:35Z","timestamp":1769692895276,"version":"3.49.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T00:00:00Z","timestamp":1644364800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Japanese Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>We conducted a nationwide survey of tomotherapy for malignant pleural mesothelioma (MPM) in Japan. Fifty-six facilities were surveyed and data on 31 patients treated curatively between 2008 and 2017 were collected from 14 facilities. Twenty patients received hemithorax irradiation after extrapleural pneumonectomy (EPP) (first group). Five patients received irradiation without EPP (second group), while six received salvage radiotherapy for local recurrence (salvage group). Among the seven patients not undergoing EPP, five (four in the second group and one in the salvage group) were treated with lung sparing pleural irradiation (LSPI) and two with irradiation to visible tumors. Two-year overall survival (OS) rates in the first and second groups were 33% and 60%, respectively (median, 13 vs 30\u00a0months, P\u2009=\u20090.82). In the first and second groups, 2-year local control (LC) rates were 53 and 67%, respectively (P\u2009=\u20090.54) and 2-year progression-free survival (PFS) rates were 16% and 60%, respectively (P\u2009=\u20090.07). Distant metastases occurred in 15 patients in the first group and three in the second group. In the salvage group, the median OS was 18\u00a0months. Recurrence was observed in the irradiated volume in four patients. The contralateral lung dose was higher in LSPI than in hemithorax irradiation plans (mean, 11.0\u2009\u00b1\u20092.2 vs 6.1\u2009\u00b1\u20093.1\u00a0Gy, P\u2009=\u20090.002). Grade 3 or 5 lung toxicity was observed in two patients receiving EPP and hemithorax irradiation, but not in those undergoing LSPI. In conclusion, outcomes of EPP and hemithorax irradiation were not satisfactory, whereas LSPI appeared promising and encouraging.<\/jats:p>","DOI":"10.1093\/jrr\/rrab127","type":"journal-article","created":{"date-parts":[[2022,1,12]],"date-time":"2022-01-12T15:37:15Z","timestamp":1642001835000},"page":"281-289","source":"Crossref","is-referenced-by-count":3,"title":["Survey of malignant pleural mesothelioma treatment in Japan: Patterns of practice and clinical outcomes in tomotherapy facilities"],"prefix":"10.1093","volume":"63","author":[{"given":"Mikiko","family":"Nakanishi-Imai","sequence":"first","affiliation":[{"name":"Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, 467-8601, Japan"},{"name":"Department of Radiology, Japanese Red Cross Aichi Medical Center, Nagoya Daini Hospital, Nagoya, 466-8650, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Murai","sequence":"additional","affiliation":[{"name":"Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, 467-8601, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiro","family":"Onishi","sequence":"additional","affiliation":[{"name":"Oncology Center, Hidaka Hospital, Takasaki, 370-0001, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuto","family":"Mouri","sequence":"additional","affiliation":[{"name":"Saitama Medical University International Medical Center Comprehensive Cancer Center, Department of Respiratory Medicine, Hidaka, 350-1298, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Komiyama","sequence":"additional","affiliation":[{"name":"Department of Radiology, Faculty of Medicine, University of Yamanashi, Chuo, 409-3898, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoko","family":"Omura","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Shonan Kamakura General Hospital, Kamakura, 247-8533, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shigehiro","family":"Kudo","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Saitama Cancer Center, Saitama, 362-0806, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Miyamoto","sequence":"additional","affiliation":[{"name":"Hokuto Hospital Department of Radiation Therapy, Obihiro, 080-0833, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Hoshino","sequence":"additional","affiliation":[{"name":"Northern Fukushima Medical Center, Date, 960-0502, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology Kizawa Memorial Hospital, Minokamo, 505-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuko","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Fukui-ken Saiseikai Hospital, Fukui, 918-8503, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masahiko","family":"Koizumi","sequence":"additional","affiliation":[{"name":"Department of Radiology, Nozaki Tokushukai Hospital, Daito, 574-0074, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junichi","family":"Omagari","sequence":"additional","affiliation":[{"name":"Department of Radiology, Koga Hospital 21, Fukuoka, 839-0801, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Mayahara","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Kobe Minimally-invasive Cancer Center, Kobe, 650-0046, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katsuyuki","family":"Karasawa","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology, Department of Radiology, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, 113-8677, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiyuki","family":"Okumura","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mito Kyodo General Hospital, Mito, 310-0015, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuta","family":"Shibamoto","sequence":"additional","affiliation":[{"name":"Department of Radiology, Nagoya City University Graduate School of Medical Sciences, Nagoya, 467-8601, Japan"},{"name":"Narita Memorial Proton Center, Toyohashi, 441-8021, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2022,2,9]]},"reference":[{"key":"2022032516122430700_ref1","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.2017.76.6394","article-title":"Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology clinical practice guideline","volume":"36","author":"Kindler","year":"2018","journal-title":"J Clin Oncol"},{"key":"2022032516122430700_ref2","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2017-211321","article-title":"British Thoracic Society guideline for the investigation and management of malignant pleural mesothelioma","volume":"73","author":"Woolhouse","year":"2018","journal-title":"Thorax"},{"key":"2022032516122430700_ref3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1136\/oemed-2019-106012","article-title":"Global and regional burden of cancer in 2016 arising from occupational exposure to selected carcinogens: a systematic analysis for the global burden of disease study 2016","volume":"77","author":"Collaborators GBDOC","year":"2020","journal-title":"Occup Environ Med"},{"key":"2022032516122430700_ref4","doi-asserted-by":"crossref","first-page":"e532","DOI":"10.1016\/S1470-2045(17)30459-X","article-title":"Radiotherapy for the treatment of malignant pleural mesothelioma","volume":"18","author":"Perrot","year":"2017","journal-title":"Lancet Oncol"},{"key":"2022032516122430700_ref5","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s10147-015-0925-1","article-title":"Trimodality strategy for treating malignant pleural mesothelioma: results of a feasibility study of induction pemetrexed plus cisplatin followed by extrapleural pneumonectomy and postoperative hemithoracic radiation (Japan mesothelioma interest group 0601 trial)","volume":"21","author":"Hasegawa","year":"2016","journal-title":"Int J Clin Oncol"},{"key":"2022032516122430700_ref6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.7785\/tcrtexpress.2013.600280","article-title":"Helical and static-port tomotherapy using the newly-developed dynamic jaws technology for lung cancer","volume":"14","author":"Manabe","year":"2015","journal-title":"Technol Cancer Res Treat"},{"key":"2022032516122430700_ref7","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/j.ijrobp.2006.03.012","article-title":"Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma","volume":"65","author":"Allen","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2022032516122430700_ref8","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/1748-717X-8-68","article-title":"Intensity-modulated radiation therapy using static ports of tomotherapy (TomoDirect): comparison with the TomoHelical mode","volume":"8","author":"Murai","year":"2013","journal-title":"Radiat Oncol"},{"key":"2022032516122430700_ref9","doi-asserted-by":"publisher","first-page":"233","DOI":"10.21037\/atm.2017.03.78","article-title":"Intraoperative intracavitary hyperthermic chemotherapy for malignant pleural mesothelioma","volume":"5","author":"Okabe","year":"2017","journal-title":"Ann Transl Med"},{"key":"2022032516122430700_ref10","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.lungcan.2016.12.015","article-title":"Pharmacokinetic evaluation of intrapleural perfusion with hyperthermic chemotherapy using cisplatin in patients with malignant pleural effusion","volume":"104","author":"Sakaguchi","year":"2017","journal-title":"Lung Cancer"},{"key":"2022032516122430700_ref11","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J Clin Oncol"},{"key":"2022032516122430700_ref12","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the mesothelioma Avastin cisplatin Pemetrexed study (MAPS): a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet"},{"key":"2022032516122430700_ref13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial","volume":"397","author":"Baas","year":"2021","journal-title":"Lancet"},{"key":"2022032516122430700_ref14","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/S0140-6736(14)60418-9","article-title":"Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): an open-label, randomised, controlled trial","volume":"384","author":"Rintoul","year":"2014","journal-title":"Lancet"},{"key":"2022032516122430700_ref15","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S1470-2045(11)70149-8","article-title":"Extra-pleural pneumonectomy versus no extra-pleural pneumonectomy for patients with malignant pleural mesothelioma: clinical outcomes of the mesothelioma and radical surgery (MARS) randomised feasibility study","volume":"12","author":"Treasure","year":"2011","journal-title":"Lancet Oncol"},{"key":"2022032516122430700_ref16","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1016\/S1470-2045(15)00208-9","article-title":"Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17\/04): a randomised, international, multicentre phase 2 trial","volume":"16","author":"Stahel","year":"2015","journal-title":"Lancet Oncol"},{"key":"2022032516122430700_ref17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.radonc.2019.05.024","article-title":"Pattern of failure after adjuvant radiotherapy following extrapleural pneumonectomy of pleural mesothelioma in the SAKK 17\/04 trial","volume":"138","author":"Riesterer","year":"2019","journal-title":"Radiother Oncol"},{"key":"2022032516122430700_ref18","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1097\/SLA.0000000000000903","article-title":"Extrapleural pneumonectomy in the treatment of epithelioid malignant pleural mesothelioma: novel prognostic implications of combined N1 and N2 nodal involvement based on experience in 529 patients","volume":"260","author":"Sugarbaker","year":"2014","journal-title":"Ann Surg"},{"key":"2022032516122430700_ref19","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/j.jtcvs.2014.10.128","article-title":"Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma","volume":"149","author":"Baldini","year":"2015","journal-title":"J Thorac Cardiovasc Surg"},{"key":"2022032516122430700_ref20","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1097\/JTO.0b013e3181ed0489","article-title":"A systematic review of extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"5","author":"Cao","year":"2010","journal-title":"J Thorac Oncol"},{"key":"2022032516122430700_ref21","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.radonc.2009.03.011","article-title":"Pulmonary toxicity following IMRT after extrapleural pneumonectomy for malignant pleural mesothelioma","volume":"92","author":"Kristensen","year":"2009","journal-title":"Radiother Oncol"},{"key":"2022032516122430700_ref22","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.ijrobp.2015.06.029","article-title":"Radical radiation therapy after lung-sparing surgery for malignant pleural mesothelioma: survival, pattern of failure, and prognostic factors","volume":"93","author":"Minatel","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2022032516122430700_ref23","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ijrobp.2014.05.032","article-title":"Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma","volume":"90","author":"Rimner","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2022032516122430700_ref24","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1200\/JCO.2016.67.2675","article-title":"Phase II study of hemithoracic intensity-modulated pleural radiation therapy (IMPRINT) as part of lung-sparing multimodality therapy in patients with malignant pleural mesothelioma","volume":"34","author":"Rimner","year":"2016","journal-title":"J Clin Oncol"},{"key":"2022032516122430700_ref25","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.jtho.2017.02.026","article-title":"Improved outcomes with modern lung-sparing trimodality therapy in patients with malignant pleural mesothelioma","volume":"12","author":"Shaikh","year":"2017","journal-title":"J Thorac Oncol"},{"key":"2022032516122430700_ref26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.prro.2020.02.007","article-title":"Disease-related outcomes and toxicities of intensity modulated radiation therapy after lung-sparing pleurectomy for malignant pleural mesothelioma: a systematic review","volume":"10","author":"Patel","year":"2020","journal-title":"Pract Radiat Oncol"}],"container-title":["Journal of Radiation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jrr\/article-pdf\/63\/2\/281\/42947002\/rrab127.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jrr\/article-pdf\/63\/2\/281\/42947002\/rrab127.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T21:15:35Z","timestamp":1648242935000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jrr\/article\/63\/2\/281\/6524746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,9]]},"references-count":26,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,2,9]]},"published-print":{"date-parts":[[2022,3,17]]}},"URL":"https:\/\/doi.org\/10.1093\/jrr\/rrab127","relation":{},"ISSN":["0449-3060","1349-9157"],"issn-type":[{"value":"0449-3060","type":"print"},{"value":"1349-9157","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,3]]},"published":{"date-parts":[[2022,2,9]]}}}